Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS

Clinical trial NCT03799718 · COMPLETED

Trial details

NCT number: NCT03799718
Sponsor: Brainstorm-Cell Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Chronic Progressive

Start date: 2019-03-13
Primary completion: 2021-03-11
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.